BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.3532
+0.0064 (1.85%)
At close: Apr 1, 2025, 4:00 PM
0.3528
-0.0004 (-0.12%)
After-hours: Apr 1, 2025, 7:56 PM EDT

BioAtla Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
--123.46-106.48-95.4-35.85
Upgrade
Depreciation & Amortization
-1.221.21.331.01
Upgrade
Loss (Gain) From Sale of Assets
-00.010-
Upgrade
Stock-Based Compensation
-13.5414.5625.123.02
Upgrade
Other Operating Activities
----0.69-1.15
Upgrade
Change in Accounts Payable
-5.283.417.99-1.66
Upgrade
Change in Unearned Revenue
-----0.43
Upgrade
Change in Other Net Operating Assets
--0.6-3.12-0.57-1.27
Upgrade
Operating Cash Flow
--104.02-90.42-62.21-36.33
Upgrade
Capital Expenditures
--0.1-0.27-0.92-0.59
Upgrade
Sale of Property, Plant & Equipment
--0--
Upgrade
Investing Cash Flow
--0.1-0.27-0.92-0.59
Upgrade
Long-Term Debt Issued
----3.43
Upgrade
Net Debt Issued (Repaid)
----3.43
Upgrade
Issuance of Common Stock
-0.3461.9771.42200.23
Upgrade
Repurchase of Common Stock
--0.26-0.76--
Upgrade
Other Financing Activities
----1.91-4.34
Upgrade
Financing Cash Flow
-0.0861.2169.51271.83
Upgrade
Net Cash Flow
--104.04-29.476.37234.9
Upgrade
Free Cash Flow
--104.11-90.69-63.14-36.92
Upgrade
Free Cash Flow Margin
----25255.20%-8606.99%
Upgrade
Free Cash Flow Per Share
--2.18-2.33-1.83-4.38
Upgrade
Levered Free Cash Flow
--61.29-51.52-48.83-9.12
Upgrade
Unlevered Free Cash Flow
--61.29-51.52-48.83-8.25
Upgrade
Change in Net Working Capital
7.25-5.1-0.5814.07-13.98
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q